Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Proffered paper session - Thoracic cancers

Overall survival (OS) from the AURA3 phase III study: Osimertinib vs platinum-pemetrexed (plt-pem) in patients (pts) with EGFR T790M advanced non-small cell lung cancer (NSCLC) and progression on a prior EGFR-tyrosine kinase inhibitor (TKI)

Date

22 Nov 2019

Session

Proffered paper session - Thoracic cancers

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Yi-Long Wu

Citation

Annals of Oncology (2019) 30 (suppl_9): ix157-ix181. 10.1093/annonc/mdz437

Authors

Y. Wu1, T.S.K. Mok2, J. Han3, M. Ahn4, A. Delmonte5, S.S. Ramalingam6, S. Kim7, F.A. Shepherd8, J. Laskin9, Y. He10, H. Akamatsu11, W.S.M.E. Theelen12, W. Su13, T. John14, M. Sebastian15, H. Mann16, M. Miranda16, G. Laus17, Y. Rukazenkov17, V. Papadimitrakopoulou18

Author affiliations

  • 1 Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, 510080 - Guangzhou/CN
  • 2 Department Of Clinical Oncology, Chinese University of Hong Kong, Hong Kong/HK
  • 3 Center For Lung Cancer, National Cancer Center, Goyang/KR
  • 4 Department Of Hematology And Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 135-710 - Seoul/KR
  • 5 Department Of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola/IT
  • 6 Department Of Hematology And Medical Oncology, Emory University School of Medicine Winship Cancer Institute, 30322 - Atlanta/US
  • 7 Department Of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul/KR
  • 8 Cancer Clinical Research Unit, Princess Margaret Cancer Center, M5G 2M9 - Toronto/CA
  • 9 Department Of Medicine, BC Cancer Agency, V5Z 4E6 - Vancouver/CA
  • 10 Department Of Respiratory Disease, Daping Hospital, Chongqing/CN
  • 11 Internal Medicine Iii, Wakayama Medical University Hospital, 641-8509 - Wakayama/JP
  • 12 Department Of Thoracic Oncology, The Netherlands Cancer Institute, 1006 BE - Amsterdam/NL
  • 13 Department Of Oncology, National Cheng Kung University Hospital, Tainan/TW
  • 14 Department Of Medical Oncology, Olivia Newton-John Cancer Research Institute, 3084 - Melbourne/AU
  • 15 Department Of Hematology/medical Oncology, University Hospital Frankfurt, 60590 - Frankfurt am Main/DE
  • 16 Oncology R&d, AstraZeneca, Cambridge/GB
  • 17 Global Medicines Development, AstraZeneca, SG8 6HB - Cambridge/GB
  • 18 Department Of Thoracic Head And Neck Medical Oncology, The University of Texas, MD Anderson Cancer Center, 77030-4095 - Houston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.